Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma

Medicine (United States)

Volumn 96, Issue 32, 2017, Pages

  Shi, Wenxia ^a   Zhang, Zili ^b   Yang, Bin ^a   Guo, Hua ^a   Jing, Li ^a   Liu, Tong ^a   Luo, Ying ^a   Liu, Hui ^a   Li, Yayue ^a   Gao, Yingtang ^a  

^a Tianjin Institute of Hepatobiliary Disease   (China)

^b THIRD CENTRAL HOSPITAL OF TIANJIN   (China)

Author keywords

hepatocellular carcinoma; Let 7; microRNA; prognosis

Indexed keywords

COL1A2 PROTEIN, HUMAN; COLLAGEN TYPE 1; MICRORNA; MIRNLET7 MICRORNA, HUMAN;

BIOSYNTHESIS; DISEASE COURSE; DOWN REGULATION; EARLY CANCER DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; COLLAGEN TYPE I; DISEASE PROGRESSION; DOWN-REGULATION; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 85027552579     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000007764     Document Type: Article

References (33)

1. Ambros V. microRNAs: Tiny regulators with great potential. Cell 2001;107:823-6.
2. Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics 2010;11:537-61.
3. Boyerinas B, Park SM, Hau A, et al. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010;17:F19-36.
4. Balzeau J, Menezes MR, Cao S, et al. The LIN28/let-7 pathway in cancer. Front Genet 2017;8:31.
5. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6.
6. Wu L, Nguyen LH, Zhou K, et al. Precise let-7 expression levels balance organ regeneration against tumor suppression. Elife 2015;4: e09431.
7. Ji J, Zhao L, Budhu A, et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010; 52:690-7.
8. Zhu Z, Jiang Y, Chen S, et al. An insertion/deletion polymorphism in the 30 untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population. Cancer Genet 2011;204:265-9.
9. Grimson A, Farh KK, Johnston WK, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007;27:91-105.
10. Garcia DM, Baek D, Shin C, et al. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 2011;18:1139-46.
11. Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
12. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet (London, England) 2012;379:1245-55.
13. Sorrentino A, Liu CG, Addario A, et al. Role of microRNAs in drugresistant ovarian cancer cells. Gynecol Oncol 2008;111:478-86.
14. Boren T, Xiong Y, Hakam A, et al. MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol 2009;113:249-55.
15. Heo I, Joo C, Cho J, et al. Lin28mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 2008;32:276-84.
16. Motoyama K, Inoue H, Nakamura Y, et al. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 2008;14:2334-40.
17. Smits KM, Paranjape T, Nallur S, et al. A let-7 microRNA SNP in the KRAS 30UTR is prognostic in early-stage colorectal cancer. Clin Cancer Res 2011;17:7723-31.
18. Zhu XM, Wu LJ, Xu J, et al. Let-7c microRNA expression and clinical significance in hepatocellular carcinoma. J Int Med Res 2011;39: 2323-9.
19. Liu C, Kelnar K, Vlassov AV, et al. Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 2012;72:3393-404.
20. Lawrie CH, Chi J, Taylor S, et al. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 2009;13:1248-60.
21. Lu L, Katsaros D, de la Longrais IA, et al. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 2007;67: 10117-22.
22. Jiang J, Gusev Y, Aderca I, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008;14:419-27.
23. Lampertico P, Agarwal K, Berg T, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370-98.
24. Wu G, Huang P, Ju X, et al. Lin28B over-expression mediates the repression of let-7 by hepatitis B virus X protein in hepatoma cells. Int J Clin Exp Med 2015;8:15108-16.
25. Takata A, Otsuka M, Ohno M, et al. Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7. Sci Rep 2016; 6:23237.
26. Moroy T, Marchio A, Etiemble J, et al. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 1986;324:276-9.
27. Chang J, Guo JT, Jiang D, et al. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 2008;82:8215-23.
28. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NFkappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009;139:693-706.
29. Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009;15:79-80.
30. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012;4:143-59.
31. Johnson SM, GrosshansH, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47.
32. Hu X, Guo J, Zheng L, et al. The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Mol Cancer Res 2013;11:240-50.
33. Han HB, Gu J, Zuo HJ, et al. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J Pathol 2012; 226:544-55.